SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense volatility as investors debate the sustainability of AI-driven memory demand following a significant price pullback. The community is actively discussing the stock's resilience at key support levels, with many traders framing the recent price action as a strategic shakeout by institutional investors.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing intense volatility following a soft Q3 revenue forecast, with the community sharply divided between bulls citing the company's massive buyback program and long-term value, and bears focused on slowing growth, increased competition, and leadership concerns. Investors are actively debating whether to accumulate shares at current levels or wait for further downside, as social sentiment remains split between optimism for a recovery and frustration over recent performance.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amid a broad sell-off in technology and semiconductor stocks as investors increasingly scrutinize the long-term ROI of high-growth AI infrastructure investments. Market participants are actively discussing key support levels, the risks of heavy institutional rotation, and the potential impact of geopolitical tensions on market stability.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is seeing heightened community discussion as investors weigh the stock's significant recent pullback against long-term growth prospects fueled by massive infrastructure demand and institutional backing. Many are actively debating the stock's valuation relative to its contracted backlog while closely monitoring upcoming earnings and the performance of its ChronoScale stake for signals of a potential turnaround.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is experiencing heightened volatility and significant price consolidation as investors weigh aggressive capital expenditure plans against long-term AI infrastructure growth. The community remains deeply divided, with many traders debating whether the current selloff represents a strategic buying opportunity or a deeper repricing of the stock's valuation.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical shares are experiencing significant volatility as investors weigh a strong earnings beat against concerns over slowing U.S. procedure growth and cautious future guidance. The community remains divided, with many viewing the sharp sell-off as a rare buying opportunity for a dominant long-term compounder, while others express frustration over valuation premiums and intensifying competitive pressures.

Sweetgreen, Inc. owns and operates a chain of salad restaurants. It offers drinks, sides, local bowls, salads, plates, and warm bowls. The company was founded by Nicolas Jammet, Jonathan Neman, and Nathaniel E. Ru in November 2006 and is headquartered in Los Angeles, CA.

Sweetgreen Inc - Ordinary Shares - Class A

Sweetgreen shares are rallying as the company was officially cleared of involvement in a recent Cyclospora outbreak that had been incorrectly linked to its supply chain, effectively removing a major source of reputational and financial pressure. The community is actively discussing this as a prime 'buy the fear' opportunity, with many traders optimistic that the resolution, combined with the successful rollout of new menu items like wraps, positions the stock for a sustained recovery.

Phoenix Asia Holdings Ltd. engages in the substructure works and other construction services. It offers site formation, ground investigation and foundation work through it subsidiary. The company was founded on August 9, 2024 and is headquartered in Hong Kong.

Phoenix Asia Holdings Ltd.

Phoenix Asia Holdings is trending due to a significant $1 billion acquisition deal that has fueled speculation of a massive short squeeze among retail traders. The community is focused on the stock's low float and rising cost-to-borrow, leading to aggressive 'buy-and-hold' campaigns and optimistic targets.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility as semiconductor stocks grapple with a sell-off triggered by concerns over hyperscaler AI spending and fears of an oversupply in memory chips. The community is sharply divided, with bulls actively buying the dip based on long-term infrastructure demand while bears argue that an AI bubble is bursting and leveraged exposure is creating a dangerous liquidation cycle.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market sentiment remains highly polarized as investors weigh ongoing geopolitical tensions against aggressive sector rotation out of AI and technology stocks. The community is actively debating whether current pullbacks represent a healthy correction or the start of a broader trend breakdown, with heavy focus on navigating volatility through 0DTE options and monitoring key support levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BDTX Broadens EGFR Reach into Glioblastoma, Adding a Fresh Catalyst

Black Diamond is expanding silevertinib into glioblastoma, adding long-term CNS-driven optionality while NSCLC remains the nearer-term focus.

Black Diamond Stock Outlook After Q1 Beat and Cash Runway

BDTX's Q1 beat and cash runway into 2028 keep focus on silevertinib's clinical durability, CNS profile and pivotal path.

BDTX Silevertinib Data in EGFR NSCLC: What Investors Need to Know

Black Diamond's May 2026 silevertinib update showed steady NSCLC response rates, CNS activity and dose progress, but durability data remain early.

What's Going On With Black Diamond Therapeutics Stock Tuesday?

Black Diamond Therapeutics (NASDAQ: BDTX) stock climbs. Get the latest technical analysis, moving averages, and price action.read more...

BDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study Data

Black Diamond Therapeutics shares sink as phase II silevertinib data show NSCLC efficacy and CNS activity, but raise investor concerns on the early nature of the dataset.

BDTX Shares Gain 11% in a Week: Here's What You Should Know

Black Diamond stock rises after its Q1 results reflect lower costs, a cash runway into 2028 and continued progress for lead candidate silevertinib.

Black Diamond Therapeutics (BDTX) to Release Quarterly Earnings on Monday

Black Diamond Therapeutics (NASDAQ:BDTX) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-black-diamond-therapeutics-inc-stock...

HC Wainwright Issues Positive Forecast for BDTX Earnings

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Free Report) - HC Wainwright upped their Q1 2026 earnings estimates for shares of Black Diamond Therapeutics in a research note issued on Wednesday...

Implied Volatility Surging for Black Diamond Therapeutics Stock Options

Investors need to pay close attention to BDTX stock based on the movements in the options market lately.

Jefferies Financial Group Upgrades Black Diamond Therapeutics (NASDAQ:BDTX) to Strong-Buy

Jefferies Financial Group upgraded shares of Black Diamond Therapeutics to a "strong-buy" rating in a report on Thursday...

Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases. It is currently focused on advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Black Diamond Therapeutics Inc

Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Year-High

Equity

Bearish Sentiment

Broad Domestic Equity

Broad International Equity

Sector / Thematic Equity

Private Markets

Which type of ETFs are you interested in? 
 
*Sponsored by Calamos and S&amp;P Global

Stocktwits

Which type of ETFs are you interested in? 
 
*Sponsored by Calamos and S&P Global

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.20	--	--	N/A
Q1 '26	-$0.18	-$0.16	13.25%	BEAT
Q4 '25	-$0.18	-$0.27	-50.93%	MISSED
Q3 '25	-$0.23	-$0.15	35.98%	BEAT
Q2 '25	-$0.25	-$0.19	23.23%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

BDTXBlack Diamond Therapeutics Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest BDTX News